Tutorial: AAI 2016 Massachusetts General Hospital : Using the iQue Screener for high throughput screening of small molecules and CRISPRs in a system of myeloid progenitors
This tutorial describes how researchers at Massachusetts General Hospital used the Intellicyt platform to conduct a high throughput functional screen (leukemia screen) of small molecules to evaluate their therapeutic potential in Acute Myeloid Leukemia (AML).
This tutorial highlights the ability of the iQue Screener to:
Perform phenotypic screening of large compound libraries for cell function
Perform target identification and validation studies with genetic permutation screens like CRISPR
Measure differentiation, viability and apoptosis as well as cytokine release over a time continuum
Complete the form below to watch this tutorial and learn more.